Markers of macrophage differentiation in experimental silicosis
暂无分享,去创建一个
D. Lison | F. Huaux | P. Misson | V. Barbarin | S. Brule
[1] S. Dhanasekaran,et al. FIZZ1 stimulation of myofibroblast differentiation. , 2004, The American journal of pathology.
[2] P. De Baetselier,et al. Alternatively activated macrophages during parasite infections. , 2004, Trends in parasitology.
[3] M. Suga,et al. Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[4] S. Phan,et al. Dual Roles of IL-4 in Lung Injury and Fibrosis1 , 2003, The Journal of Immunology.
[5] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[6] Kazuhiko Yamamoto,et al. Role of interferon-gamma in the development of murine bronchus-associated lymphoid tissues induced by silica in vivo. , 2002, Toxicology and applied pharmacology.
[7] John Parkinson,et al. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype , 2002, BMC Immunology.
[8] P. De Baetselier,et al. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages , 2002, Journal of leukocyte biology.
[9] C. Dawson,et al. L-Arginine uptake and metabolism following in vivo silica exposure in rat lungs. , 2002, American journal of respiratory cell and molecular biology.
[10] J. Hibbs. Infection and nitric oxide. , 2002, The Journal of infectious diseases.
[11] E. Pearce,et al. Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern of l-Arginine Metabolism1 , 2001, The Journal of Immunology.
[12] R. Homer,et al. Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.
[13] J. Renauld,et al. Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. , 2001, American journal of respiratory cell and molecular biology.
[14] T. Wynn,et al. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. , 2000, The American journal of pathology.
[15] F. Peale,et al. FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene family , 2000, The EMBO journal.
[16] Kristi Kincaid,et al. M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.
[17] T. Gotoh,et al. Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. , 1999, American journal of physiology. Endocrinology and metabolism.
[18] J. Renauld,et al. Lung fibrosis induced by silica particles in NMRI mice is associated with an upregulation of the p40 subunit of interleukin-12 and Th-2 manifestations. , 1999, American journal of respiratory cell and molecular biology.
[19] D. Hemenway,et al. Expansion of interferon-gamma-producing lung lymphocytes in mouse silicosis. , 1999, American journal of respiratory cell and molecular biology.
[20] M. Munder,et al. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. , 1998, Journal of immunology.
[21] L. Chiesa,et al. A new procedure for the specific high-performance liquid chromatographic determination of hydroxyproline. , 1997, Journal of chromatographic science.
[22] M. Takiguchi,et al. Coinduction of Nitric-oxide Synthase and Arginase I in Cultured Rat Peritoneal Macrophages and Rat Tissues in Vivo by Lipopolysaccharide* , 1997, The Journal of Biological Chemistry.
[23] M. Caldwell,et al. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. , 1997, The American journal of physiology.
[24] C. Nathan,et al. Nitric oxide and macrophage function. , 1997, Annual review of immunology.
[25] D. Lamb,et al. A type 2 (Th2‐like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA) , 1995, Clinical and experimental immunology.
[26] B. Wallaert,et al. Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. , 1995, The European respiratory journal.
[27] B. Wallaert,et al. Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity. , 1994, American journal of respiratory and critical care medicine.
[28] S. Gordon,et al. Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ , 1994, European journal of immunology.
[29] S Gordon,et al. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.
[30] G. M. Ridder,et al. Pulmonary response to silica or titanium dioxide: inflammatory cells, alveolar macrophage-derived cytokines, and histopathology. , 1990, American journal of respiratory cell and molecular biology.